October 6th, 2017
Positioning Digital PCR for Sharper Genomic Views
In this Genetic Engineering article, Alexandra Martin (Sales Application Specialist), Ph.D. was interviewed about the use of Digital PCR in the oncology field. She highlights a study on four common EGFR mutations in non-small cell lung cancer patients where they’re monitoring the correlation between mutations and treatment.
At Stilla Technologies, we aim to make Digital PCR a lab commodity as any other PCR technique. Alexandra highlights Digital PCR advantages and the naica® System workflow over Next Generation Sequencing: higher sensitivity, lower price and faster time-to-result…